English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [64]
News [222]
Articles [19]
Editorials [2]
Conferences [40]
elearning [2]
Multiple tumours without kinship occur simultaneously in the small intestine
Multiple tumours without kinship occur simultaneously in the small intestine
COVID-19 and cancer: Useful resources
COVID-19 and cancer: Useful resources
ESMO 2021: Tyrosine kinase inhibitor prolongs progression-free survival in rare neuroendocrine tumour
ESMO 2021: Tyrosine kinase inhibitor prolongs progression-free survival in rare neuroendocrine tumou...
Study reveals neuroendocrine tumor mortality patterns to inform treatment decisions
Study reveals neuroendocrine tumor mortality patterns to inform treatment decisions
Study reveals neuroendocrine tumour mortality patterns to inform treatment decisions
Study reveals neuroendocrine tumour mortality patterns to inform treatment decisions
New treatment proves more effective and less toxic for neuroendocrine tumour patients
New treatment proves more effective and less toxic for neuroendocrine tumour patients
Cancer trial participation does not eliminate disparities for poor patients
Cancer trial participation does not eliminate disparities for poor patients
Machine learning can identify cancerous cells by their acidity
Machine learning can identify cancerous cells by their acidity
Natural "brake" against malignant neuroblastoma
Natural "brake" against malignant neuroblastoma
Study finds high tumour mutation burden predicts immunotherapy response in some, but not all, cancers
Study finds high tumour mutation burden predicts immunotherapy response in some, but not all, cancer...
<12345...23>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307